Renal Autologous Cell Therapy/Neo-Kidney Augment(TM) (REACT/NKA): Phase II Study of REACT/NKA Implantation in Type 2 Diabetes with Pre-Stage 5 Chronic Kidney Disease Renal Autologous Cell Therapy/Neo-Kidney Augment(TM) (REACT/NKA): Phase II study of REACT/NKA implantation in Type 2 Diabetes with Pre-Stage 5 Chronic Kidney Disease Joseph Stavas, Tim Bertram, Deepak Jain, Ashely Johns, David Gerber, Prabir Roy-Chaudhury, George Bakris
